By:- Saurav Kasera, Founder, CLIRNET
Knowledge has never been more abundant. Yet access to the right knowledge at the right time remains one of healthcare’s biggest challenges. Clinical guidelines are revised constantly, research output is growing every year, and new diagnostics and therapies reach the market faster than most practitioners can track. The real question a clinician faces is narrower and harder: how does the latest evidence reach the specific patient sitting in front of them, right now.
That question has two parts. The first is access at the point of care, a drug interaction, a revised dosing guideline, a contraindication that needs verifying inside a two- or three-minute consultation, not after it. The second is continuity, the fact that a patient’s clinical history is scattered across hospitals and systems that rarely talk to each other, leaving the next doctor to start from an incomplete picture.
Neither problem stems from a shortage of doctors entering the system. India’s MBBS seats have crossed one lakh nationally, nearly doubling since 2014. Yet doctor density remains close to 0.7 per 1,000 people, well under WHO benchmarks, and in several rural districts one doctor is effectively responsible for well over a thousand patients. Nurse density tells a similar story, and even the WHO’s figure of roughly 1.7 per 1,000 understates it, since it counts headcount rather than whether a newly qualified nurse can work independently without months of additional training. The pipeline is expanding. What still fails to arrive is evidence at the moment it is needed, and a complete record when the next consultation begins.
Technology is starting to close both gaps, not by replacing clinical judgment but by putting better information within reach of it.
1. Point-of-care reference tools put verification inside the consultation itself. Apps that check drug interactions, dosing and contraindications in seconds have replaced what used to mean pausing a consultation to consult a printed formulary. This is the one place a knowledge gap has an immediate cost, and it is the one place technology has closed the distance most directly.
2. Digital CME has made learning continuous instead of occasional. Clinical guidelines now change several times a year, sometimes within weeks, as seen during the pandemic’s shifting guidance on oxygen therapy and corticosteroids. Mobile-first platforms, recorded masterclasses and short evidence explainers mean a practitioner no longer waits for the next annual conference to know a protocol has changed.
3. AI-assisted literature filtering, used narrowly, turns volume into something usable. Thousands of papers publish every week, more than any clinician can track alongside a full practice. The defensible use of AI here is surfacing what is relevant to a specific specialty and case, not generating clinical advice, which remains a genuinely risky application regardless of how it is marketed.
4. Electronic health records are starting to solve continuity, slowly. The technology to digitise a patient’s history has existed for years; what has lagged is hospitals actually connecting their systems instead of storing records in isolation. National digital health initiatives are pushing interoperability forward, and every connection made is one less patient beginning a consultation with an incomplete history.
5. Secure digital communities are making multidisciplinary judgment easier to reach. A diabetologist and a periodontist can now discuss the implications of GLP-1 receptor agonists in a patient with advanced periodontal disease without arranging a formal referral. An oncologist can consult a molecular pathologist before selecting targeted therapy. Veterinarians, physicians and public health experts collaborate through One Health frameworks on emerging zoonotic risk. None of this required new expertise to exist. It required a faster route to the expert who already had it.
6. Mobile-first delivery has separated expertise from geography. A dentist in a small city or a vet serving a remote farming community can now access the same expert-led discussion as a colleague in Mumbai or Delhi. Participation data from Tier-2 and Tier-3 towns has consistently shown the appetite for high-quality learning was never the missing ingredient. Access was.
7. Interoperability standards are quietly becoming the infrastructure that ties the rest together. Individual records, individual apps and individual learning platforms each solve a piece of the problem in isolation. Shared health data standards are what determine whether a patient’s history and a clinician’s evidence actually meet at the point of decision, rather than existing as two separate, well-built systems that never speak to each other.
None of this replaces the judgment clinicians build over years of practice, and none of it will substitute for India continuing to invest in hospitals, colleges and workforce expansion. What it does is shrink the distance between what medicine already knows and what reaches the patient in the room. That distance, more than any shortage of information, is the knowledge gap worth closing next.